MiMedx Group, Inc.

( )
MDXG After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -1.20%136.260.0%$876.09m
AMGNAmgen, Inc. 0.19%243.871.5%$800.58m
GILDGilead Sciences, Inc. -0.21%62.241.0%$521.82m
VRTXVertex Pharmaceuticals, Inc. 3.02%254.171.9%$450.04m
REGNRegeneron Pharmaceuticals, Inc. 1.47%655.012.6%$404.30m
ILMNIllumina, Inc. 0.08%233.743.3%$282.61m
NVAXNovavax, Inc. -7.50%48.0075.7%$279.78m
BIIBBiogen, Inc. -0.37%198.381.8%$245.45m
BNTXBioNTech SE -4.81%151.200.0%$211.21m
SNSSSunesis Pharmaceuticals, Inc. 13.90%2.130.7%$148.89m
EXASEXACT Sciences Corp. -3.33%50.5517.7%$132.03m
NKTXNkarta, Inc. -1.14%13.860.0%$111.92m
TECHBio-Techne Corp. -1.53%362.134.5%$98.39m
BMRNBioMarin Pharmaceutical, Inc. -0.53%77.324.2%$97.55m
TXG10X Genomics, Inc. -2.79%46.300.0%$89.30m

Company Profile

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.